Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis

Clinical and Applied Thrombosis/Hemostasis

Volumn 14, Issue 3, 2008, Pages 360-364

  Sucker, Christoph ^a   Mansmann, Georg ^a   Steiner, Stefan ^a   Gattermann, Norbert ^a   Schmitt Graeff, Anette ^b   Loncar, Robert ^a   Scharf, Rudiger E ^a   Stockschlader, Marcus ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Fatal bleeding; Heparin like anticoagulants; Systemic mastocytosis

Indexed keywords

2 CHLORODEOXYCHLORADENOSINE; ANTIHISTAMINIC AGENT; ARYLSULFATASE; CHYMASE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; CYTOSTATIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; HEPARIN DERIVATIVE; HISTAMINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 9; KININ; LEUKOTRIENE; PEGINTERFERON ALPHA2A; PROSTAGLANDIN; PROTAMINE; SEROTONIN; TISSUE PLASMINOGEN ACTIVATOR; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; AUTOPSY; BLEEDING; CASE REPORT; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DISEASE PREDISPOSITION; DIZZINESS; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HISTOPATHOLOGY; HUMAN; LABORATORY DIAGNOSIS; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; RARE DISEASE; RHINORRHEA; SIDE EFFECT; SYNCOPE; SYSTEMIC MASTOCYTOSIS; THROMBIN TIME; URTICARIA; VOMITING;

ADULT; ANTICOAGULANTS; BONE MARROW; FATAL OUTCOME; FEMALE; HEMORRHAGE; HEPARIN; HUMANS; MAST CELLS; MASTOCYTOSIS, SYSTEMIC;

EID: 45749091765     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029607309173     Document Type: Article

References (31)

1. Hartmann K., Henz BM Mastocytosis: recent advances in defining the disease. Br J Dermatol. 2001 ; 144: 682-695.
2. Delling G., Ritzel H., Wener M. Histologische Charakteristika und Häufigkeit der sekundären Osteoporose bei systemischer Mastozytose. Pathologie. 2001 ; 22: 132-140.
3. Valent P., Horny HP, Li C., et al. Mastocytosis (mast cell disease). In: Jaffe ES, Harris NL, Stein H, Cardiman JW, eds. World Health Organization (WHO) classification of tumours. Pathology Genetics. Tumours of Haemoatopoietic and lymphoid tissues. Geneva, Switzerland: WHO ; 2001: 291-302.
4. Tefferi A., Pardanani A. Clinical, genetic, and therapeutic insights into systemic mast cell disease. Curr Opin Hematol. 2004 ; 11: 58-64.
5. Tefferi A., Pardanani A. Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep. 2004 ; 3: 197-202.
6. Valent P., Akin C., Sperr WR, et al. Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol. 2003 ; 122: 695-717.
7. Crivellato E., Beltrami CA, Mallardi F., et al. The mast cell; an active participant or an innocent bystander. Histol Histopathol. 2004 ; 19: 259-270.
8. Ruggiero M., Melli M., Parma B., Bianchini P., Vannucchi S. Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects. Pathophysiol Haemost Thromb. 2002 ; 32: 44-49.
9. Bussel JB, Steinherz PG, Miller DR, Hilgartner MW A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia. Am J Pathol. 1984 ; 16: 83-90.
10. Horne MK III, Chao ES, Wilson OJ, Scialla SJ, Lynch MA, Kragel PJ A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma. J Lab Clin Med. 1991 ; 118: 250-260.
11. Palmer RN, Rick ME, Rick PD, Zeller JA, Gralnick MD Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med. 1984 ; 310: 1696-1699.
12. Garnier G., Taillan B., Castanet J., Pesce A., Dujardin P. Heparin-like anticoagulant in small cell bronchial carcinoma. Rev Med Interne. 1991 ; 12: 213-214.
13. Llamas P., Outeirino J., Espinoza J., Santos AB, Roman A., Tomas JF Report of three cases of circulating heparin-like anticoagulants. Am J Hematol. 2001 ; 67: 256-258.
14. Hill GR, Hickton CM, Brennan SO, Atkinson CH, Heaton DC Acquired heparin-like anticoagulants: a second case in metastatic breast carcinoma and literature review. Clin Lab Haematol. 1996 ; 18: 291-295.
15. Goihman Yahr M., Goldstein C., Gonzalez Y., et al. A clinical constellation in disuse: vitiligo, mastocytosis of the bone marrow, circulating heparinoid, chronic leg ulcer, hypoalbuminemia, ulcerative colitis and hepatic fibrosis. Med Cutan Ibero Lat Am. 1977 ; 5: 229-234.
16. Guillet GY, Dore N., Maleville J. Heparin liberation in urticaria pigmentosa. Arch Dermatol. 1982 ; 118: 532-533.
17. Nenci GG, Berrettini M., Parise P., Agnelli G. Persistent spontaneous heparinaemia in systemic mastocytosis. Folia Haematol Int Mag Klin Morphol Blutforsch. 1982 ; 109: 453-463.
18. Smith TF, Welch TR, Allen JB, Sondheimer JM Cutaneous mastocytosis with bleeding: probable heparin effect. Cutis. 1987 ; 39: 241-244.
19. Hansen U., Wiese R., Knolle J. Shock and coagulation disorders in systemic mastocytosis. Dtsch Med Wochenschr. 1994 ; 119: 1231-1234.
20. Tefferi A., Nichols WL, Bowie EJ Circulating heparin-like anticoagulants: report of five consecutive cases and a review. Am J Med. 1990 ; 88: 184-188.
21. Tefferi A., Owen BA, Nichols WL, Witzig TE, Owen WG Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinoma. Blood. 1989 ; 74: 252-254.
22. Wages DS, Staprans I., Hambleton J., Bass NM, Corash L. Structural characterization and functional effects of a circulating heparan sulfate in a patient with hepatocellular carcinoma. Am J Hematol. 1998 ; 58: 285-292.
23. Horne MK III, Chao ES, Wilson OJ Heparin-like anticoagulant associated with systemic candidiasis. Am J Hematol. 1990 ; 35: 37-44.
24. Lasser EC, Simon RA, Lyon SG, Hamblin AE, Stein R. Heparin-like anticoagulants in asthma. Allergy. 1987 ; 42: 619-625.
25. Cassese E., Piscitelli V., Di Grazia F., Di Prisco L., Balbi C., Balbi GC Heparin-like factors in pregnancy. Report of a clinical case. Minerva Ginecol. 1998 ; 50: 435-440.
26. Sawers AH, Davson J., Braganza J., Geary CG Systemic mastocytosis, myelofibrosis and portal hypertension. J Clin Pathol. 1982 ; 35: 617-619.
27. Jarosova A., Filip V., Monhart V., Limberk B. Circulating heparin-like anticoagulant-2 cases of successful therapy. Vnitr Lek. 1992 ; 38: 513-517.
28. Hauswirth AW, Simonitsch-Klupp I., Uffmann M., et al. Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature. Leuk Res. 2004 ; 28: 249-257.
29. Worobec AS Treatment of systemic mast cell disorders. Hematol Oncol Clin North Am. 2000 ; 14: 659-687.
30. Kluin-Nelemans HC, Oldhoff JM, Van Doormaal JJ, Van 't Wout JW, Verhoef G., Gerrits WB, van Dobbenburgh OA, Pasmans SG, Fijnheer R. Cladribine therapy for systemic mastocytosis. Blood. 2003 ; 102: 4270-4276.
31. Akin C., Fumo G., Avuz AS, Lipsky PE, Neckers I., Metcalfe DD A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib. Blood. 2004 ; 103: 3222-3225.